SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has appointed Susan Mahony ...

SOMERSET, N.J., February 20, 2025--(BUSINESS WIRE)--Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has ...

He served as CEO of Catalent from 2009 to 2015, then as Chair and CEO from 2016 through 2022, and as Executive Chair until June 2023. Under his leadership, Catalent grew into a global Tier 1 CDMO ...

John Chiminski brings more than three decades of leadership in healthcare and pharma services. He served as CEO of Catalent from 2009 to 2015, then as Chair and CEO from 2016 through 2022, and as ...

He served as CEO of Catalent from 2009 to 2015 ... EW healthcare Partners that contributed its portfolio company, ABL, Inc. in late 2024, Ascend offers expanded commercial manufacturing, process ...

EightCAP, Inc., a Community Action Agency dedicated to helping people and changing lives, is excited to announce the launch of its new logo and brand identity. This rebranding initiative reflects ...

DelveInsight's High Potency Active Pharmaceutical Ingredients Market Insights report provides the current and forecast market ...

Jupiter Neurosciences (JUNS) announced a strategic partnership with Aquanova to jointly develop a series of consumer-focused nutritional ...

Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings' purchase of Catalent and the sale of three manufacturing facilities to Novo Nordisk.